1 |
Nef HM,Möllmann H,Akashi YJ,et al.Mechanisms of stress (Takotsubo) cardiomyopathy[J].Nat Rev Cardiol,2010,7(4):187-193.
|
2 |
Maron BJ,Towbin JA,Thiene G,et al.Contemporary definitions and classification of the cardiomyopathies:an American Heart Association scientific statement from the council on clinical cardiology,heart failure and transplantation committee;quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups;and council on epidemiology and prevention[J].Circulation,2006,113(14):1807-1816.
|
3 |
Lacey C,Mulder R,Bridgman P,et al.Broken heart syndrome-is it a psychosomatic disorder?[J].J Psychosom Res,2014,77(2):158-160.
|
4 |
Hanoman HH.Apical balloon syndrome(Takotsubo stress cardiomyopathy)or aborted myocardial infarction[J].West Indian Med J,2010,59(2):232.
|
5 |
Dote K,Sato H,Tateishi H,et al.Myocardial stunning due to simultaneous multivessel coronary spasms:a review of 5 cases[J].J Cardiol,1991,21(2):203-214.
|
6 |
Raman B,Singh K,Zeitz CJ,et al.Takotsubo cardiomyopathy presenting as S-T elevation myocardial infarction:not gone but forgotten?[J].Int J Cardio,2014,172(1):e261-e262.
|
7 |
Szardien S,Möllmann H,Willmer M,et al.Mechaism of stress(takotsubo) cardiomyopathy[J].Heart Fail Clin,2013,9(2):197-205.
|
8 |
Templin C,Ghadri JR,Diekmann J,et al.Clinical features and outcomes of takotsubo(Stress)cardiomyopathy[J].N Engl J Med,2015,373(10):929-938.
|
9 |
Wittstein IS,Thiemann DR,Lima JAC,et al.Neurohumoral features of myocardial stunning due to sudden emotional stress[J].N Engl J Med,2005, 352(6):539-548.
|
10 |
Ghadri JR,Wittstein IS,Prasad A,et al.International expert consensus document on takotsubo syndrome(Part I):clinical characteristics,diagnostic criteria,and pathophysiology[J].Eur J Heart,2018,39(22):2032-2046.
|
11 |
Roth TL,Nayak D,Atanasijevic T,et al.Transcranial amelioration of inflammation and cell death after brain injury[J].Nature,2014,505(7482):223-228.
|
12 |
Tsikas D.Assessment of lipid peroxidation by measuring malondialdehyde(MDA)and relatives in biological samples:analytical and biological challenges[J].Anal Biochem,2017(524):13-30.
|
13 |
Kwiecien S,Jasnos K,Magierowski M,et al.Lipid peroxidation,reactive oxygen species and antioxidative factors in the pathogenesis of gastric mucosal lesions and mechanism of protection against oxidative stress-induced gastric injury[J].J Physiol Pharmacol,2014,65(5):613-622.
|
14 |
Müller MC,Tuinman PR,Vlaar AP,et al.Contribution of damage-associated molecular patterns to transfusion-related acute lung injury in cardiac surgery[J].Blood transfus,2014,12(3):368-375.
|
15 |
Madhavan M,Prasad A.Proposed mayo clinic criteria for the diagnosis of Tako-Tsubo cardiomyopathy and long-term prognosis[J].Herz,2010,35(4):240-243.
|
16 |
中国医师协会急诊医师分会,国家卫健委能力建设与继续教育中心急诊学专家委员会,中国医疗保健国际交流促进会急诊急救分会.急性冠脉综合征急诊快速诊治指南(2019)[J].临床急诊杂志,2019,20(4):253-262.
|
17 |
Wischnewsky MB,Candreva A,Bacchi B,et al.Prediction of shortand long-term mortality in takotsubo syndrome:the interTAK prognostic score[J].Eur J Heart Fail,2019,21(11):1469-1472.
|
18 |
Almendro-Delia M,Núñez-Gil IJ,Lobo M,et al.Short-and long-term prognostic relevance of cardiogenic shock in takotsubo syndrome:results from the RETAKO registry[J].JACC Heart Fail,2018,6(11):928-936.
|
19 |
Redfors B,Vedad R,Angerås O,et al.Mortality in takotsubo syndrome is similar to mortality in myocardial infarction-a report from the SWEDEHEART registry[J].Int J Cardiol,2015(185):282-289.
|
20 |
Pelliccia F,Pasceri V,Patti G,et al.Long-term prognosis and outcome predictors in takotsubo syndrome[J].JACC Heart Failure,2019,7(2):143-154.
|
21 |
Sattler K,El-Battrawy I,Lang S,et al.Prevalence of cancer in takotsubo cardiomyopathy:short and long-term outcome[J].Int J Cardiol,2017(238):159-165.
|
22 |
Cammann VL,Sarcon A,Ding KJ,et al.Clinical features and outcomes of patients with malignancy and takotsubo syndrome:observations from the international takotsubo registry[J].J Am Heart Assoc,2019,8(15):e010881.
|
23 |
Sharkey SW,Kalra A,Henry TD,et al.Coexistence of acute takotsubo syndrome and acute coronary syndrome[J].Catheter Cardiovasc Interv,2020,96(4):825-829.
|
24 |
Gu Xy,Fang T,Kang P,et al.Effect of ALDH2 on high glucose-induced cardiac fibroblast oxidative stress,apoptosis,and fibrosis[J].Oxid Med Cell Longev,2017(2017):9257967.
|
25 |
Penna C,Perrelli MG,Pagliaro P.Mitochondrial pathways,permeability transition pore,and redox signaling in cardioprotection:therapeutic implications[J].Antioxid Redox Signal,2013,18(5):556-599.
|
26 |
Chouchani ET,Pell VR,Gaude E,et al.Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS[J].Nature,2014,515(7527):431-435.
|
27 |
Pillai VB,Samant S,Sundaresan NR,et al.Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3[J].Nat Commun,2015(6):6656.
|
28 |
Scally C,Abbas H,Ahearn T,et al.Myocardial and systemic inflammation in acute stress-induced(Takotsubo)cardiomyopathy[J].Circulation,2019,139(13):1581-1592.
|
29 |
Pirzer R,Elmas E,Haghi D,et al.Platelet and monocyte activity markers and mediators of inflammation in takotsubo cardiomyopathy[J].Heart Vessels,2012,27(2):186-192.
|
30 |
Nef HM,Möllmann H,Troidl C,et al.Expression profiling of cardiac genes in tako-tsubo cardiomyopathy:insight into a new cardiac entity[J].J Mol Cell Cardiol,2008,44(2):395-404.
|
31 |
Morel O,Sauer F,Imperiale A,et al.Importance of inflammation and neurohumoral activation in takotsubo cardiomyopathy[J].J Card Fail,2009,15(3):206-213.
|